News
-
-
PRESS RELEASE
Le vaccin IXCHIQ® de Valneva contre le chikungunya désormais autorisé au Canada pour les personnes âgées de 12 ans et plus
Valneva obtient l'autorisation de Santé Canada pour son vaccin IXCHIQ® contre le chikungunya chez les + de 12 ans. Le vaccin est approuvé en Europe pour les adolescents. Les données de phase 3 montrent une réponse immunitaire durable -
-
-
-
-
-
PRESS RELEASE
Xebra Brands Announces Share Consolidation and Provides Update on MCTO
Xebra Brands Ltd. announces a consolidation of common shares on a 10:1 basis. No fractional shares will be issued. Update on management cease trade order and expected filing of Annual Financial Filings by August 29, 2025 -
PRESS RELEASE
TAG signs agreement to acquire a substantial portfolio of rental units in Poland; on this basis and following the financial performance in H1 2025, increased dividend planned from 2026 onwards
TAG Immobilien AG signs agreement to acquire substantial rental unit portfolio in Poland, plans increased dividend from 2026, supported by strong financial performance in H1 2025 -